Articles
8,065 Articles
Psychedelics Today
/
Jul 15, 2025
Erica Rex: Scientific Integrity, Psychedelic Research, and the Religious Leader Study
In this episode, Joe Moore speaks with award-winning science journalist Erica Rex about her personal experience participating in psychedelic research, her upcoming book Seeing What Is There: My Search for Sanity in the Psychedelic Era, and the complex story behind the recently published Religious...
Psilocybin
Microdose
/
Jul 15, 2025
Enveric’s EB-003 Shows Promise in PTSD Model, Offering a New Direction in Trauma Treatment
In the shadow of headlines about the mental health crisis and the limits of current psychiatric care, one small biotech is making quiet but meaningful progress. Enveric Biosciences (NASDAQ: ENVB) announced this week that its lead drug candidate, EB-003, demonstrated a rapid therapeutic effect in a...
DoubleBlind Mag
/
Jul 14, 2025
Could ICE Raid Psychedelic Spaces?
Could ICE Raid Psychedelic Spaces? Plus, why Hollywood can't get ayahuasca right, the case for trip-free psychedelics, and Mary Carreon, Glauber Loures de Assis, PhD, Adana Omágua Kambeba, MD & Jairo Lima 14 Jul Together with EntheoDNA Good morning and welcome back to the Drop In,...
MDMA
Ayahuasca
Psychedelics
Psilocybin Alpha
/
Jul 14, 2025
Pα+ Psychedelic Bulletin #203: Norway Considers Funding Off-Label Ketamine for TRD; Longevity Crowd Hypes Psilocybin Study; Will State-Legal Psychedelics Eat Psychedelic Pharma’s Lunch?
The Norwegian Medical Products Agency (Direktoratet for medisinske produkter or DMP) has published its health technology assessment (HTA) of intravenous ketamine for treatment-resistant depression (TRD). It said that it was commissioned to conduct the review in the context of growing interest in...
Psilocybin
Ketamine
Psychedelics
DoubleBlind Mag
/
Jul 11, 2025
Is Ego Death Going Mainstream with the God Molecule?
Is Ego Death Going Mainstream with the God Molecule? Scientists explore how 5-MeO-DMT dissolves the ego, while biotech firms rush to turn it into a treatment, and a billion-dollar business. Mattha Busby 11 Jul Deep dives and investigations you won't find anywhere else Inside the Push to...
Third Wave Blog
/
Jul 09, 2025
Paul F. Austin Featured in MysticMag: A Deep Dive into Psychedelics, Coaching, and Cultural Change
Third Wave's Read the full interview for more on Paul’s efforts to shape the next chapter of the psychedelic rennaissance. Written by Michael B.
DoubleBlind Mag
/
Jul 09, 2025
Scientists, Advocates Sound Alarm on DEA Psychedelic Ban
Scientists, Advocates Sound Alarm on DEA Psychedelic Ban Experts warn DEA’s plan could halt breakthroughs in psychedelic science and threaten public health. Jack Gorsline 09 Jul Together with EntheoDNA Your weekly dose of psychedelic insights and news Leading Advocates Warn DEA’s...
Psychedelics
Third Wave
/
Jul 09, 2025
Paul F. Austin Featured in MysticMag: A Deep Dive into Psychedelics, Coaching, and Cultural Change
Third Wave's Read the full interview for more on Paul’s efforts to shape the next chapter of the psychedelic rennaissance. Written by Michael B.
Psychedelics Today
/
Jul 08, 2025
Daniel Pinchbeck – From Cultural Catalyst to Capitalist Co-option: Reflections on Psychedelic Science, AI, and Idealist Monism
In this expansive episode of Psychedelics Today, Joe Moore sits down with author and cultural theorist Daniel Pinchbeck to explore the evolving—and increasingly contested—role of psychedelics in society. From the hopeful spirit of transformation that animated earlier psychedelic movements to the...
Psychedelics
DoubleBlind Mag
/
Jul 07, 2025
Here’s What an Acid Researcher Says About LSD for Depression
Here's What an Acid Researcher Says About LSD for Depression PLUS how to take GHB, new events, and more! Mary Carreon // Senior Editor 07 Jul Together with ENTHEO* Good morning and welcome back to the Drop In, DoubleBlind’s newsletter delivering independent journalism about psychedelics...
LSD
Mescaline
DMT
MDMA
GHB
DoubleBlind Mag
/
Jul 04, 2025
That Time A$AP Rocky Took LSD with a Psychedelic Scientist
That Time A$AP Rocky Took LSD with a Psychedelic Scientist An LSD trip with a neuroscientist turned Rocky’s London sessions into one of his biggest creative experiments. Mattha Busby 04 Jul Deep dives and investigations you won't find anywhere else Meet the Psychedelic Scientist Who...
LSD
Psilocybin Alpha
/
Jul 03, 2025
Reconstructing Meaning: Chris Timmermann on the Neurophenomenology of Psychedelics
Chris Timmermann PhD is one of the UK’s leading researchers at the frontier of consciousness science. A Research Fellow in Neuroscience, Meditation and Psychedelics at University College London, and former Head of the DMT Research Group at Imperial College London’s Centre for Psychedelic...
DMT
Psychedelics
Psychedelics Today
/
Jul 03, 2025
Mattha Busby: Power, Pleasure, and the Psychedelic Movement’s Reckoning
In this wide-ranging conversation, journalist Mattha Busby joins Joe Moore to reflect on the shifting tone of the psychedelic movement in the wake of Psychedelic Science 2025. Based in Vancouver, Mattha has written for The Guardian, VICE, Esquire, TIME, and Wired, bringing a uniquely embedded yet...
DoubleBlind Mag
/
Jul 02, 2025
Why Radical Rest Matters Now More Than Ever
Why Radical Rest Matters Now More Than Ever An intimate look at how mothers, artists, and activists are reclaiming rest as essential for change. Sophia Kercher 02 Jul SUPPORTING PARTNER Your weekly dose of psychedelic insights and news The Case for Radical Rest Why relaxation is...
MDMA
Lucid News
/
Jul 01, 2025
Speakers at PS2025 Challenge the Psychedelic Movement, Announce a Clergy Study, and Explore Psychedelics For Brain Injury
On June 19, the second day of the 2025 Psychedelic Science conference in Denver, CO, Lucid News reporters continued to cover panel discussions and events. These stories followed several talks, including psychologist Carl Hart’s presentation about psychedelic exceptionalism and the writer Jamie...
Psilocybin
LSD
MDMA
Psychedelics
Psychedelics Today
/
Jul 01, 2025
Dylan Beynon – Mindbloom – At Home Ketamine
PT welcomes Dylan Beynon, CEO and Founder of Mindbloom, one of the largest providers of legal, at-home ketamine therapy in the U.S. Dylan shares the deeply personal story that led him to psychedelic medicine—including the tragic loss of his mother and sister to addiction and mental illness—and...
Ketamine
DoubleBlind Mag
/
Jun 30, 2025
Tripping on High-Dose LSD Shows Promise for Depression Relief
Tripping on High-Dose LSD Shows Promise for Depression Relief Plus DMT orgasms, effects of music on the tripping brain, and mushroom potency. Mary Carreon // Senior Editor 30 Jun TOGETHER WITH ENTHEO* Good morning! Welcome back to The Drop In, DoubleBlind’s newsletter delivering...
LSD
DMT
MDMA
Psychedelics Today
/
Jun 28, 2025
It’s Time to Push Back: Meta’s War on Psychedelic Voices
META is doing real damage to the psychedelic ecosystem.Shadowbans. Post removals. Account suspensions. Entire orgs—especially nonprofits—shut out of digital visibility with no explanation and no recourse. This is absurd, especially given how much money we’ve collectively spent advertising on...
DoubleBlind Mag
/
Jun 27, 2025
Tripping in an Italian Forest Morphed into an Art Project
Tripping in an Italian Forest Morphed into an Art Project Two friends took mushrooms in a forest…and never stopped going back. Johnny Magdaleno 27 Jun Deep dives and investigations you won't find anywhere else How a Mushroom Trip Turned Into a Years-Long Art Project in the Forest After...
Psychedelics Today
/
Jun 27, 2025
Victoria Litman – The Future of Psychedelic Regulation Is Local
In this episode, we sit down with Victoria Litman, M.Div., J.D., LL.M., to discuss why the future of psychedelic access in the United States is being shaped not by federal agencies, but by the bold actions of individual states. As a legal scholar and writer focusing on drug policy, Victoria breaks...
Psilocybin Alpha
/
Jun 27, 2025
Pα+ Psychedelic Bulletin #202: Psychedelics Access ‘Within 12 Months’, RFK Jr. Says; Psychedelics in Washington; Lykos’ New CEO, CMO; New Zealand’s First Psilocybin Prescriber; Judge Recommends Schedule I Placement for DOI and DOC
We returned from Psychedelic Science 2025 to a very busy week, not least due to Compass Pathways’ first Phase 3 readout (read our piece on researchers’ reactions). We’re expecting the remainder of June to be similarly eventful, so this Bulletin aims to get you up to speed with various...
Psilocybin
Psychedelics
Psilocybin Alpha
/
Jun 25, 2025
Cautious Optimism, Lingering Questions: Researchers React to Compass’ Phase 3 Psilocybin Results
It’s been two days since Compass Pathways provided a first look at data from its Phase 3 program, by way of a limited readout from COMP005, a placebo-controlled study of its COMP360 psilocybin in treatment-resistant depression (TRD). (See Compass Pathways’ Psilocybin Clears First Phase 3...
Psilocybin
DoubleBlind Mag
/
Jun 25, 2025
Was John C. Lilly a Genius or a Madman?
Was John C. Lilly a Genius or a Madman? Inside the Mind of John C. Lilly: LSD, Isolation Tanks, and Dolphin Talk Jasmine Virdi 25 Jun SUPPORTING PARTNER Your weekly dose of psychedelic insights and news Tripping on LSD in Isolation Tanks and Talking to Dolphins Dismissed as a madman...
LSD
MDMA
DoubleBlind Mag
/
Jun 24, 2025
Can Psychedelics Go Mainstream If Public Awareness Is Low?
Can Psychedelics Go Mainstream If Public Awareness Is Low? New survey reveals how the public perceives psychedelics, PLUS how to manage a psychedelic god complex, MDA, and reimagining capitalism. Mary Carreon // Senior Editor 24 Jun SUPPORTING PARTNER Good morning and welcome back to the...
Psilocybin
Ketamine
Psychedelics
Lucid News
/
Jun 24, 2025
Day 1: PS2025 Opens With Pardons by Colorado Govenor Polis
Lucid News is publishing daily roundups of news from Psychedelic Science 2025, including coverage of talks and events that took place during the last three days of the conference. The coverage below is a continuation of Wednesday’s, June 18 talks. Our reporters cover psychedelics in athletics,...
DMT
MDMA
Lucid News
/
Jun 21, 2025
Day 1: Psychedelic Science 2025 Examines Religious Use, the Climate Crisis, and Fungal Medicine
The MAPS 2025 Psychedelic Science conference kicked off in Denver, Colorado this week. Beginning on Wednesday, June 18, after two days of workshops, the main portion of the conference hosted a series of talks and events that offered participants a view into a range of topics impacting the...
Psychedelics
Lucid News
/
Jun 21, 2025
Psychedelic Science 2025 Examines Religious Use, the Climate Crisis, Fungal Medicine, and the Shulgin Legacy
The MAPS 2025 Psychedelic Science conference kicked off in Denver, Colorado this week. Beginning on June 18, after two days of workshops, the main portion of the conference hosted a series of talks and events that offered participants a view into a range of topics impacting the psychedelic...
Psychedelics
Psychedelics Today
/
Jun 20, 2025
PS 25 Morning Show – Day Three
Joe Moore and Anne Philippi (New Health Club) are hosts of the PS25 Morning Show! This one features Cesar Marin, AnneClaire Stapleton, Dennis Walker, Jonathan Sabbagh, Tom Feegel and Philip Graf von Drechsel! And thats a wrap for PS25!!
Psychedelics Today
/
Jun 20, 2025
PS 25 Morning Show – Day Two
Joe Moore and Anne Philippi (New Health Club) are hosts of the PS25 Morning Show! This one features Daniel Goldberg (Palo Santo) and Zac Kamenetz (Shefa Flow)!
DoubleBlind Mag
/
Jun 20, 2025
Can a Cloud Forest Hold Copyright?
Can a Cloud Forest Hold Copyright? A song co-written with birds, bats, and trees raises profound legal and philosophical questions. Jasmine Virdi 20 Jun Deep dives and investigations you won't find anywhere else Can a Forest Maintain Its Creative Rights? Some Legal Experts Say Yes. A...
Psychedelics Today
/
Jun 19, 2025
PS 25 Morning Show – Day One
Joe Moore and Anne Philippi (New Health Club) are hosts of the PS25 Morning Show! This one features Dee Dee Goldpaugh, LCSW and Tommaso Barba, PhDC! We talk about all things Sex and Psychedelics!
Psychedelics Today
/
Jun 18, 2025
When it Comes to Psychedelic Access, It’s the Messenger, Not the Message
By Robert Johnson No one in the 21st-century psychedelic pantheon has crossed over to the mainstream like writer Michael Pollan. His 2018 book How to Change Your Mind (an immediate #1 New York Times bestseller) was a “before and after” in terms of the psychedelic conversation. Pollan’s work...
DoubleBlind Mag
/
Jun 18, 2025
The Psychedelic Rock Canon, Rewired
The Psychedelic Rock Canon, Rewired Yes, of course the Dead and Hendrix are on here. But so is Spiritualized, Panda Bear, Love, and Flying Lotus. Peter Holslin 18 Jun SUPPORTING PARTNER Your weekly dose of psychedelic insights and news Good Vibrations: The Top 25 Psychedelic...
LSD
Psilocybin Alpha
/
Jun 17, 2025
Australia’s Largest Private Health Insurer Commits $10M to Fund MDMA Therapy for PTSD in First-of-its-Kind Program
Australia’s largest private health insurer, Medibank, has launched a first-of-its-kind funding program for MDMA-assisted therapy for PTSD as part of its ‘innovative psychotherapy program’. That makes it the first payor in the country to back psychedelic-assisted psychotherapy. The AUD $10...
MDMA
Lucid News
/
Jun 17, 2025
Whistleblowers Claim 2024 MA Psychedelics Ballot Initiative Violated Campaign Finance Laws
Part 1 of a series. Two former campaign staffers who helped lead the Yes on 4 ballot initiative that would have regulated psychedelic therapy and decriminalized psychedelic use and home cultivation in Massachusetts have filed a series of complaints to the state Office of Campaign and Political...
Psychedelics
Psychedelics Today
/
Jun 16, 2025
Ibogaine and the Future of Healing: Trevor Millar & Jonathan Dickinson of Ambio Life Sciences
In this episode of Psychedelics Today, kicking of Psychedelic Science 2025 week in Denver, we sit down with Jonathan Dicksinson, Chief Executive Officer, and Trevor Millar, Chief Operations Officer of Ambio Life Sciences – one of the world’s leading ibogaine clinics – to explore the potential...
Psychedelics